Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 4859

Journal of Addiction Research & Therapy received 4859 citations as per Google Scholar report

Journal of Addiction Research & Therapy peer review process verified at publons
Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • SafetyLit
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
Share This Page

Hannu Alho

National Institute for Health and Welfare, Department of Mental Health and Substance Abuse Services, Helsinki, Finland

Biography

Dr. Hannu Alho received his MD in 1981 from the University of Tampere, Finland. After his MD/PhD Thesis in 1984 from University of Tampere, he was a Visiting Fellow at the NIMH in Washington DC, USA in 1984-86 and Associate Professor at Georgetown University in 1986-89. He received the specialty of Addiction Medicine in 2001. Since 2006 he has been a research Professor at National Institute of Health and Welfare, Helsinki Finland, and since 2008 Full Professor of Addiction Medicine at the University of Helsinki, Finland. 
Publications

Predictors of Self-Reported Adherence to Naltrexone Medication in an Outpatient Treatment for Problem Drinking

Objective: The opioid antagonist naltrexone has been proven as an efficacious treatment for alcoholism. However, in clinical trials the reported medication adherence has often been poor, being one of the key problems associated with naltrexone treatment. There are very few studies on predictors of nonadherence, although this information would help ... Read More»

Vuoristo-Myllys Salla, Esti Laaksonen, Jari Lahti, Jari Lipsanen, Hannu Alho and Hely Kalska

Research Article: J Addict Res Ther 2013, 4: 159

DOI: 10.4172/2155-6105.1000159

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

Relevant Topics
Top